lsq

In today's podcast, Craig Jeffery sits down with Vikas Shah from LSQ for a discussion on the pressing need for companies to focus on driving cost savings and improving liquidity. Vikas shares specific examples of how businesses are finding cost savings and adding scalability, along with a look into key market challenges such as increased demand, credit deterioration, and the importance of process efficiency.

Learn more about LSQ here.

Today’s podcast guest heads up a – relatively – small but highly effective Brisbane-based manufacturer, Bioproton.
Its main competitors, though, are large, multinational companies with deep pockets. 
Size, though – says Bioproton’s manager Juhani Von Hellens – isn’t everything when it comes to producing successful, high-quality products that meet market needs … but agility is. 

Substantial experience in medical research, research management and research strategy development have prepared today’s podcast guest, Dr Claudia Giurgiuman for her role as CEO of Wesley Medical Research.

With more than two decades in medical research, Claudia has developed executive-level skills in collaborative development, strategic implementation and change facilitation.

Since 2019, her diverse role has seen her primarily responsible for delivering the organisation’s strategic goals and providing strong academic and research leadership.

Claudia is also steering the development and growth of the Wesley Medical Research’s clinical trials and overseeing its core grant and philanthropic investment portfolio.

Our podcast guest today makes things happen in the field of life sciences … literally. 
 
More than a venture capitalist, Sarah Meibusch uses her extensive global management and development expertise … plus her entrepreneurial passion … to nurture success in life sciences organisations looking to take their business to the next level. 
 
As a principal at OneVentures, Sarah is an expert in start-ups and specialises in commercialising new technologies as well as in managing significant, successful business transitions. 

Joining us today is Professor Fabienne Mackay, the Director and CEO of QIMR Berghofer Medical Research Institute in Queensland.

Professor Mackay studied Medicine and Biomedical Engineering before obtaining her PhD in Molecular Biology and Immunology from Louis Pasteur University in Strasbourg, France, and commencing her international research career.

Among her awards is a trophy from the French Ministry of Foreign Affairs in Paris for outstanding contribution in education and research as an expatriate.

Joining us today is distinguished molecular virologist Professor Paul Young who heads the University of Queensland’s School of Chemistry and Molecular Biosciences, including the team working on a potential vaccine for COVID-19. 

Having gained his Bachelor of Science with honours at UQ and his PhD at the University of London, Professor Young has since built a career as a successful researcher, educator and administrator. 

He is also involved in research that concentrates on several infectious viruses including 

·         the dengue virus – a serious mosquito-borne disease that is endemic in many tropical countries 

·         and West Nile virus 

Join us on this podcast series as we meet the icons of the biotechnology industry, exploring the current state of innovation in Queensland and what the future holds for our best and brightest. Hosted by Anthony Frangi, each episode will feature a new guest sharing their unique angle on the capabilities of the industry in Queensland.